相关实验视频
Updated: Feb 6, 2026

08:59
A Novel In Vitro Model of Blast Traumatic Brain Injury
Published on: December 21, 2018
11.2K
在创伤性脑损伤中,S释放介导的神经保护的H2蛋白质景观
Rashi Saxena1,2, Vinod Singh Bisht3, Deepak Kumar4
1Cell Death Research Laboratory, Endocrinology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh 226031, India.
Journal of proteome research
|February 4, 2026
概括
硫化释放SVRN-4显示出治疗创伤性脑损伤 (TBI) 的前景. 这种新疗法在小鼠模型中减少了组织损伤并改善了认知功能,突出了其神经保护潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
背景情况:
- 创伤性脑损伤 (TBI) 导致严重的健康负担,由于初级和二级伤害级联.
- 目前对TBI的治疗方法有限,特别是在解决分子损伤和二次损伤进展方面.
- 硫化 (H2S) 供体具有局限性,因此需要使用替代的输送方法.
研究的目的:
- 在体重下降TBI (WD-TBI) 的小鼠模型中评估一种新的H2S释放SRN-4的治疗疗效.
- 通过蛋白质组分析和神经行为评估,研究SVRN-4的神经保护机制.
主要方法:
- 在WD-TBI的小鼠模型中施用SVRN-4.
- 评估TBI引起的组织损伤和线粒体完整性.
- 神经行为测试用于评估认知和运动功能.
- 全球蛋白质组分析以确定分子路径的改变.
主要成果:
- SVRN-4显著降低了TBI诱导的组织破坏和与氧化相关的损伤.
- 线粒体完整性得到恢复,治疗后神经认知和运动功能得到改善.
- 蛋白质组分析显示,SVRN-4使炎症标志物正常化,并恢复了与线粒体功能和ATP生产相关的蛋白质表达.
结论:
- 在TBI的小鼠模型中,SVRN-4显示出显著的神经保护作用.
- 这种可以通过恢复线粒体功能和减少炎症来改善二次损伤的进展.
- SVRN-4是促进结核病患者功能恢复的有希望的治疗候选者.
相关概念视频
Peptide Bonds
83.2K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
912
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
912
Proteomics
9.8K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.8K
Traumatic Memory
587
Emotionally traumatic events often lead to memories that are exceptionally vivid and enduring, sometimes persisting with remarkable clarity throughout an individual's life. A classic example of this phenomenon is a person who survives a car accident. Even years later, they may recall every detail of the event with startling accuracy — the screeching of the tires, the jarring impact, and the acrid smell of burning rubber. Such vividness contrasts sharply with how an individual...
587
Receptor-mediated Endocytosis
111.0K
Overview
111.0K
Energy-releasing Steps of Glycolysis
146.9K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
The first energy-releasing step—the 6th step of glycolysis...
146.9K

